Cited by 631interferon and immune responsesMitochondrial Function and PathologyRNA regulation and disease

Mitochondrial double-stranded RNA triggers antiviral signalling in humans

Open access
Dhir, Ashish, Dhir, Somdutta, Borowski, Lukasz S., Jimenez, Laura, Teitell, Michael, Rötig, Agnès, Crow, Yanick J., Rice, Gillian I. +10 more·2018·Nature

Abstract

Mitochondria are descendants of endosymbiotic bacteria and retain essential prokaryotic features such as a compact circular genome. Consequently, in mammals, mitochondrial DNA is subjected to bidirectional transcription that generates overlapping transcripts, which are capable of forming long double-stranded RNA structures 1,2. However, to our knowledge, mitochondrial double-stranded RNA has not been previously characterized in vivo. Here we describe the presence of a highly unstable native mitochondrial double-stranded RNA species at single-cell level and identify key roles for the degradosome components mitochondrial RNA helicase SUV3 and polynucleotide phosphorylase PNPase in restricting the levels of mitochondrial double-stranded RNA. Loss of either enzyme results in massive accumulation of mitochondrial double-stranded RNA that escapes into the cytoplasm in a PNPase-dependent manner. This process engages an MDA5-driven antiviral signalling pathway that triggers a type I interferon response. Consistent with these data, patients carrying hypomorphic mutations in the gene PNPT1, which encodes PNPase, display mitochondrial double-stranded RNA accumulation coupled with upregulation of interferon-stimulated genes and other markers of immune activation. The localization of PNPase to the mitochondrial inter-membrane space and matrix suggests that it has a dual role in preventing the formation and release of mitochondrial double-stranded RNA into the cytoplasm. This in turn prevents the activation of potent innate immune defence mechanisms that have evolved to protect vertebrates against microbial and viral attack.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-018-0363-0

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Defective RNAse degradation causes double-stranded mtRNA accumulation in mitochondria, cytosolic leakage, and type I interferon production.

    “defective degradation leads to double-stranded mtRNA accumulation in the organelle, subsequent cytosolic leakage of double-stranded mtRNA and type I interferon production150.”

    From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [150]

    The paper reports that loss of either mitochondrial RNA degradosome component causes double-stranded mtRNA accumulation. However, its discussion of dsRNA localization and IFNB1 induction distinguishes the two: PNPase depletion permits cytosolic release and a type I interferon response, whereas SUV3 depletion leaves the RNA restricted to mitochondria without that response. The claim is therefore too broad if 'defective degradation' includes both defects. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Some evidence supports existence of unstable double-stranded mtRNA during homeostasis.

    “although mtDNA transcription points towards the production of single-stranded mtRNA, some evidence supports the existence of unstable double-stranded mtRNA during homeostasis150.”

    From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [150]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dhir, A., Dhir, S., Borowski, L. S., Jimenez, L., Teitell, M., Rötig, A., Crow, Y. J., Rice, G. I., Duffy, D., Tamby, C., Nojima, T., Munnich, A., Schiff, M., de Almeida, C. R., Rehwinkel, J., Dziembowski, A., Szczesny, R. J., & Proudfoot, N. J.
Affiliations
  • University of Oxford (GB)
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences (PL)
  • University of California, Los Angeles (US)
  • Inserm (FR)
  • University of Manchester (GB)
Corresponding author
  • Dhir, Ashish
  • Proudfoot, Nicholas J.
Venue
Nature
Published
2018-07-25
Volume
560
Issue
7717
Pages
238-242
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2883018577
Cited by
631
References
41
Citations by year
2026: 90 · 2025: 77 · 2024: 100 · 2023: 78 · 2022: 82 · 2021: 80 · 2020: 58 · 2019: 49 · 2018: 14
FWCI
21.59
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
Funders
  • Wellcome Trust (107928, 107928/Z/15/Z)
  • European Commission (POIG.02.02.00-14-024/08, POIG.02.02.00-14-024/08-00)
  • Agence Nationale de la Recherche (ANR-10-IAHU- 01, ANR-16-CE17-0010, ANR-10-IAHU-0001, 10-IAHU-01, ANR-10, CE17001002)
  • Narodowym Centrum Nauki
  • National Institutes of Health (ANR-10-IAHU-01)
  • Medical Research Council (MC_UU_00008/8)
  • Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0428, BBS/E/B/000C0427)
  • European Regional Development Fund (02.02.00-14-024/08-00, POIG.02.02.00-14-024/08, POIG.02.02.00-14-024/08-00)
  • National Institute of General Medical Sciences (R01GM073981, GM073981, R01GM114188)
  • FP7 Ideas: European Research Council (309449, 339270)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
mitochondrial double-stranded RNA, mitochondrial DNA, bidirectional transcription, antiviral signaling, MDA5, type I interferon response, polynucleotide phosphorylase, PNPT1, degradosome, innate immunity, interferon-stimulated genes, mitochondrial matrix
MeSH terms
Interferon-Induced Helicase, IFIH1, RNA, Mitochondrial, Animals, Endoribonucleases, Exoribonucleases, Gene Expression Regulation, HeLa Cells, Humans, Interferon Type I, Mice, Inbred C57BL, Multienzyme Complexes, Mutation, Polyribonucleotide Nucleotidyltransferase, RNA, Double-Stranded, Herpesvirus 1, Human, RNA Helicases, Mitochondrial Proteins, bcl-2 Homologous Antagonist-Killer Protein, bcl-2-Associated X Protein, Mice, DEAD-box RNA Helicases, Single-Cell Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review